Cara Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
CARA on Nasdaq
Location
400 Atlantic Street, Suite 500, Stamford, CT

Insiders trading volume in the past year

Cara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Csl Ltd 10%+ Owner $9.02M Aug 9, 2022
Vifor (International) Ltd 10%+ Owner $9.02M Oct 20, 2021
Derek T. Chalmers President & CEO, Director $1.21M Sep 7, 2021
Martin Vogelbaum Director $308K Jun 4, 2024
Susan Ph.D. Shiff Director $152K Jun 4, 2024
Jeffrey L. Ives Director $149K Jun 4, 2024
Lisa von Moltke Director $137K Jun 4, 2024
Helen M. Boudreau Director $113K Jun 4, 2024
Frederique Ph.D. Menzaghi Chief Scientific Off,Svp R&D $92K Feb 1, 2024
Scott Terrillion Sec'y; Chief Compliance & G.C. $73.2K -$5.22K -6.65% Apr 5, 2024
Harrison M. Bains Jr Director $70.1K Jun 1, 2023
Christopher Posner PRESIDENT AND CEO, Director $60.4K -$35.8K -37.2% Aug 1, 2024
Thomas Charles Reilly Chief Financial Officer $46.1K Mar 3, 2022
Joana Goncalves Chief Medical Officer $44.3K -$5.22K -10.5% Apr 5, 2024
Richard Makara VP, Head of Accting;Controller $16.6K Jun 15, 2022
Ryan Maynard Chief Financial Officer $7.43K Feb 8, 2024

Recent Insider Transactions by Companies or Individuals for Cara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.